International Clinical Trial: Individualized Contrast Dosing Strategy for Prevention of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention A Multicenter, Prospective, Randomized, Open-Label, Endpoint-Blinded Trial (AIDE-PCI Trial)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131338) titled 'Individualized Contrast Dosing Strategy for Prevention of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention A Multicenter, Prospective, Randomized, Open-Label, Endpoint-Blinded Trial (AIDE-PCI Trial)' on Sept. 1.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Dongguan Xiegang Hospital

Condition: coronary heart disease

Intervention: Experimental group:AIDE assisted decision-making

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-09-01

Target Sample Size: Experimental group:1320;Control group:1320;

Countries of Recru...